Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Todd Neale

September 13, 2018

News Daily News

Diversity in Heart Failure Trials Still Falls Short

Todd Neale

August 22, 2018

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Shelley Wood

August 15, 2018

News Daily News

Valsartan Recall Expanded by FDA and European Medicines Agency

Shelley Wood

August 10, 2018

News Daily News

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

Shelley Wood

July 27, 2018

News Daily News

CVD Prevention and Control Remains a Challenge in India

L.A. McKeown

June 26, 2018

News Daily News

High CVD Risk in India Varies by State, Demographics

Todd Neale

June 20, 2018

News Daily News

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

L.A. McKeown

March 28, 2018

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

L.A. McKeown

February 15, 2018

News Daily News

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

Michael O'Riordan

February 14, 2018

News Daily News

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Michael O'Riordan

January 30, 2018

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Shelley Wood

January 17, 2018

News Daily News

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

L.A. McKeown

January 11, 2018

Advertisement

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Diversity in Heart Failure Trials Still Falls Short

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Valsartan Recall Expanded by FDA and European Medicines Agency

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

CVD Prevention and Control Remains a Challenge in India

High CVD Risk in India Varies by State, Demographics

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content